wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26801806-98463C0E-26EE-46DF-AA1A-DB210349D6DF
Q26801806-98463C0E-26EE-46DF-AA1A-DB210349D6DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26801806-98463C0E-26EE-46DF-AA1A-DB210349D6DF
Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple Integrins
P2860
Q26801806-98463C0E-26EE-46DF-AA1A-DB210349D6DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26801806-98463C0E-26EE-46DF-AA1A-DB210349D6DF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8732cedd3a6bc3d5b7ed4ec6f8563f75a0c82a6e
P2860
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.